Vaccines Market – Global Outlook & Forecast 2021-2031
Vaccines Market by Patient Type [Pediatric Patients and Adult Patients], Strain Type [Monovalent Vaccines and Multivalent Vaccines], Technology [Live Attenuated Vaccines, Conjugate Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Inactivated & Subunit Vaccines], Vaccine Type [DT Containing Vaccine; Measles, Mumps, Rubella, Varicella; Pneumococcal Conjugate Vaccine (PCV); Human Papillomavirus (HPV); Meningococcal; COVID-19; Rotavirus; Hepatitis and Influenza], Route of Administration [Oral and Parenteral] – Global Analysis & Forecast 2021-2031
Vaccines Market Introduction
Vaccine is a biological preparation that provides active acquired immunity to a particular disease. It helps the body’s immune system to recognize and fight pathogens like viruses or bacteria, which keeps us safe from the diseases they cause. Vaccines are made using the disease-causing virus or bacteria, but in a form that will not harm human body. Instead, the weakened, killed, or partial virus or bacteria prompts human body immune system to develop antibodies, or defenders, against the disease. Vaccination is one of the most effective ways to prevent diseases. Vaccines protect against debilitating or life-threatening diseases, including measles, polio, tetanus, diphtheria, meningitis, influenza, tetanus, typhoid, COVID-19, cervical cancer, etc. Vaccines are generally prepared by using five major technologies i.e., conjugate vaccines, live attenuated vaccines, toxoid vaccines, inactivated and subunit vaccines and recombinant vaccines.
Market - Headwinds & Tailwinds
The global vaccines market is mainly driven by outbreak of infectious diseases in different regions, rising awareness for immunization, growing number of new born babies globally, robust vaccine pipeline and various initiatives for making vaccine available to low- and middle-income countries. Furthermore, increasing government support for vaccine development is also playing a pivotal role in contributing to growth of the market globally. However, high cost of vaccine development and religious beliefs among certain communities regarding vaccination are likely to restrain the market growth to a certain extent.
Market Segmentation & Insights
The global vaccines market has been analyzed from six perpectives: Patient Type, Strain Type, Technology, Vaccine Type, Route of Administration and Region.
Vaccines Market by Patient Type
Based on patient type, the market has been segmented into pediatric patients and adult patients. The pediatric patients segment accounted for the largest share in the market owing to rising pediatric population and growing initiatives by public & private organizations to promote childhood immunization.
Vaccines Market by Strain Type
Based on strain type, the market has been segmented into monovalent vaccines and multivalent vaccines. The multivalent vaccines segment accounted for the largest share and is expected to be the fastest growing segment in the market during the forecast period owing to extensive development of innovative multivalent vaccines. Multivalent vaccines provide immunity against two or more strains of the same pathogen, or against two or more pathogens.
Vaccines Market by Technology
Based on technology, the vaccines market has been segmented into live attenuated vaccines, conjugate vaccines, recombinant vaccines, toxoid vaccines, inactivated and subunit vaccines. Recombinant vaccines segment is expected to be the fastest growing segment in the market during the forecast period. The growth of the segment can mainly be attributed to development and launch of several recombinant vaccines. Recombinant vaccines are developed by the application of recombinant DNA technology. It involves the insertion of DNA which encodes an antigen for the stimulation of immune response against the expressed antigen.
Vaccines Market by Vaccine Type
Based on vaccine type, the vaccines market has been segmented into DT containing vaccine; measles, mumps, rubella, varicella; pneumococcal conjugate vaccine (PCV); human papillomavirus (HPV); meningococcal; COVID-19; rotavirus; hepatitis; influenza and others (cholera, malaria, rabies, shingles, etc.). The COVID-19 segment is expected to be the fastest growing segment in the market during the forecast period. The growth of the segment can be attributed to the sudden outbreak of the COVID-19 pandemic globally; increasing investments, collaboration & funding to boost R&D activities for development of effective COVID-19 vaccine; and rising initiatives by various government bodies & numerous organizations to provide COVID-19 immunization worldwide.
Vaccines Market by Route of Administration
Based on route of administration, the vaccines market has been segmented into oral and parenteral. The parenteral segment holds the largest share in the market. Intramuscular administration is often preferred because it is easy to perform and generally well tolerated, with a low risk for adverse reactions at the site of injection. The majority of licensed vaccines in market are administered by intramuscular injection, whereas some vaccines are approved for subcutaneous or intradermal use.
Vaccines Market by Region
Based on region, the global vaccines market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW). North America dominated the vaccines market, followed by Asia Pacific. The large share of North America in the global market can largely be attributed to its developed healthcare infrastructure, presence of prominent players, and increasing government initiative for immunization programmes. According to CDC, around 70% of children aged 19-35 months has received a complete seven-vaccine series (a subset of all recommended vaccinations for this age group) in the U.S.
Competitive Landscape
The vaccines market is marked by presence of prominent players such as Merck & Co., Sanofi, GlaxoSmithKline plc., Pfizer Inc., AstraZeneca, CSL Limited, Panacea Biotec Ltd., Serum Institute of India Pvt. Ltd., PT Bio Farma (Persero), Bavarian Nordic, among others. Other players operating in the market are Bharat Biotech, Emergent BioSolutions Inc., Johnson & Johnson Private Limited, Mitsubishi Tanabe Pharma Corporation, among others.
Snapshot: Industry Developments
- In Jan 2021, Bayer signed a collaboration and service agreement with CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA). Under the terms of the agreement, Bayer will support the further development, supply and key territory operations of CureVac´s COVID-19 vaccine candidate CVnCoV
- In Dec 2020, Pune-based Serum Institute of India, the largest vaccine manufacturer in the world by doses, announced the launch of India's first indigenously developed pneumococcal vaccine “Pneumosil”
- In April 2020, Sanofi and GSK announced that they have signed a letter of intent to develop an adjuvanted vaccine for COVID-19, using innovative technology from both companies, to help address the ongoing pandemic
- In Jan 2020, Pfizer Inc. announced the launch of its Vaccines Division’s Centers of Excellence Network, a global program of collaborations with academic institutions to conduct real-world epidemiologic research to accurately identify and measure the burden of specific vaccine-preventable diseases and potentially evaluate vaccine effectiveness affecting adults
- In April 2018, Merck, announced partnership with Oxford University’s Jenner Institute to develop more robust and scalable vaccine manufacturing processes. This partnership, as well as plans to develop a vaccine manufacturing facility in Ghana, further the company’s commitment to improve global health by making vaccines more affordable and available
Key Insights Captured in the Report
- Quantitative (market size and forecasts) and qualitative insights of the market across years - historical years, current year and forecasted years
- Deep-rooted insights on headwinds, tailwinds and opportunities prevailing in the market
- Quantitative (market size and forecasts) and qualitative insights at segment and sub-segment level
- Comprehensive quantitative (market size and forecasts) and qualitative insights on geographic, regional and country level markets
- Granular insights on the competitive landscape prevailing in the market
- Competitive mapping of strategic developments
Scope of the Vaccines Market Report:
| Report Metrics | Details |
| Market Size Period | 2018-2031 |
| Base Year | 2020 |
| Forecast Period | 2021-2031 |
| Market Segments | Asessment of Vaccines Market By: • Patient Type • Strain Type • Technology • Vaccine Type • Region |
| Geographic Scope | • North America ◦ U.S. ◦ Canada • Europe ◦ Germany ◦ UK ◦ France ◦ Rest of Europe (RoE) • Asia Pacific ◦ China ◦ Japan ◦ India ◦ Rest of Asia Pacific (RoAPAC) • Rest of the World ◦ Latin America ◦ Middle East & Africa |
| Companies Covered | Merck & Co., Sanofi, GlaxoSmithKline plc., Pfizer Inc., AstraZeneca, CSL Limited, Panacea Biotec Ltd., Serum Institute of India Pvt. Ltd., PT Bio Farma (Persero), Bavarian Nordic, Bharat Biotech, Emergent BioSolutions Inc., Johnson & Johnson Private Limited, Mitsubishi Tanabe Pharma Corporation, among others. |
1 RESEARCH ENVELOPE
1.1 Market Classification
1.2 Scope of the Study
1.2.1 Timeline Considered for Market Study
· Historic Years – 2018 & 2019
· Base Year – 2020
· Projected Years – 2021 to 2031
1.3 Currency Used in the Report
2 RESEARCH METHODOLOGY
2.1 Research Approach
2.2 Data Collection Methodology
2.3 Data Sources
2.3.1 Secondary Sources
2.3.2 Primary Sources
2.4 Market Crackdown Methodology
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Data Forecasting Model
2.6 Limitations and Assumptions for Study
3 HEADWINDS & TAILWINDS ASSESSMENT
4 MARKET OPPORTUNITIES ASSESSMENT
5 PREMIUM INSIGHTS
5.1 Key Market Trends
5.2 Key Players & Their Competitive Positioning (2020)
5.3 COVID-19 Impact Assessment
5.4 Pipeline Assessment
6 GLOBAL VACCINES MARKET - ANALYSIS & FORECAST, BY PATIENT TYPE
6.1 Pediatric Patients
6.2 Adult Patients
7 GLOBAL VACCINES MARKET - ANALYSIS & FORECAST, BY STRAIN TYPE
7.1 Monovalent Vaccines
7.2 Multivalent Vaccines
8 GLOBAL VACCINES MARKET - ANALYSIS & FORECAST, BY TECHNOLOGY
8.1 Live Attenuated Vaccines
8.2 Conjugate Vaccines
8.3 Recombinant Vaccines
8.4 Toxoid Vaccines
8.5 Inactivated & Subunit Vaccines
9 GLOBAL VACCINES MARKET - ANALYSIS & FORECAST, BY VACCINE TYPE
9.1 DT Containing Vaccine
9.2 Measles, Mumps, Rubella, Varicella
9.3 Pneumococcal Conjugate Vaccine (PCV)
9.4 Human Papillomavirus (HPV)
9.5 Meningococcal
9.6 COVID-19
9.7 Rotavirus
9.8 Hepatitis
9.9 Influenza
9.10 Others (Cholera, Malaria, Rabies, Shingles, Etc.)
10 GLOBAL VACCINES MARKET - ANALYSIS & FORECAST, BY ROUTE OF ADMINISTRATION
10.1 Oral
10.2 Parenteral
11 GLOBAL VACCINES MARKET - ANALYSIS & FORECAST, BY REGION
11.1 North America Vaccines Market
11.1.1 North America Vaccines Market, By Country
11.1.1.1 U.S.
11.1.1.2 Canada
11.1.2 North America Vaccines Market, By Patient Type
11.1.3 North America Vaccines Market, By Strain Type
11.1.4 North America Vaccines Market, By Technology
11.1.5 North America Vaccines Market, By Vaccine Type
11.1.6 North America Vaccines Market, By Route of Administration
11.2 Europe Vaccines Market
11.2.1 Europe Vaccines Market, By Country/Region
11.2.1.1 Germany
11.2.1.2 U.K
11.2.1.3 France
11.2.1.4 Rest of Europe (ROE)
11.2.2 Europe Vaccines Market, By Patient Type
11.2.3 Europe Vaccines Market, By Strain Type
11.2.4 Europe Vaccines Market, By Technology
11.2.5 Europe Vaccines Market, By Vaccine Type
11.2.6 Europe Vaccines Market, By Route of Administration
11.3 Asia Pacific Vaccines Market
11.3.1 Asia Pacific Vaccines Market, By Country/Region
11.3.1.1 China
11.3.1.2 Japan
11.3.1.3 India
11.3.1.4 Rest of Asia Pacific (RoAPAC)
11.3.2 Asia Pacific Vaccines Market, By Patient Type
11.3.3 Asia Pacific Vaccines Market, By Strain Type
11.3.4 Asia Pacific Vaccines Market, By Technology
11.3.5 Asia Pacific Vaccines Market, By Vaccine Type
11.3.6 Asia Pacific Vaccines Market, By Route of Administration
11.4 Rest of the World (RoW) Vaccines Market
11.4.1 Rest of the World Vaccines Market, By Region
11.4.1.1 Latin America
11.4.1.2 Middle East & Africa
11.4.2 Rest of The World Vaccines Market, By Patient Type
11.4.3 Rest of The World Vaccines Market, By Strain Type
11.4.4 Rest of The World Vaccines Market, By Technology
11.4.5 Rest of The World Vaccines Market, By Vaccine Type
11.4.6 Rest of The World Vaccines Market, By Route of Administration
12 COMPANY PROFILES
12.1 Merck & Co.
12.1.1 Business Overview
12.1.2 Financial Metrics*
12.1.3 Product Portfolio
12.1.4 Key Developments
12.2 Sanofi
12.3 GlaxoSmithKline plc.
12.4 Pfizer Inc.
12.5 AstraZeneca
12.6 CSL Limited
12.7 Panacea Biotec Ltd.
12.8 Serum Institute of India Pvt. Ltd.
12.9 PT Bio Farma (Persero)
12.10 Bavarian Nordic
*Insights on financial metrics is subject to availability of information in the public domain
Download Report Sample PDF
Specific Requirement Form
Solitary
- The solitary license authorizes only one individual to use the report
- A PDF version of the report will be delivered that can be viewed on only one authorized system
- Free analyst support for 20 hours is extended as a value-added service
- Buyers need to share the ‘Name and Email ID of the authorized user
- Imitation, distribution as well as quoting of the contents of the report is prohibited without the prior permission of Clairvoyance Research
$4850
Compound
- Compound license authorizes only 5 individuals to use the report
- A PDF/Printable version of report will be delivered that can be viewed on only 5 authorized systems
- Free analyst support for 40 hours is extended as a value-added service
- Buyers need to share ‘Names and Email IDs’ of the authorized users
- Imitation, distribution as well as quoting of the contents of the report is prohibited without the prior permission of Clairvoyance Research
$5850
Corporate
- Corporate license authorizes unlimited individuals to use the report
- A PDF/Printable version of report will be delivered that can be viewed on unlimited systems
- Free analyst support for 80 hours is extended as a value-added service
- This license type allows extraction of top-level market data tables in ‘Excel’ format and also permits the buyer to quote the contents of the report published by Clairvoyance Research
$6850
Data Pack
- Data Pack’ request provides customers all ‘Quantitative Insights’ with respect to a particular market in an excel-based dashboard format
$2250
Purchase Options
Solitary $4850
Compound $5850
Corporate $6850
Data Pack $2250
- The solitary license authorizes only one individual to use the report
- A PDF version of the report will be delivered that can be viewed on only one authorized system
- Free analyst support for 20 hours is extended as a value-added service
- Buyers need to share the ‘Name and Email ID of the authorized user
- Imitation, distribution as well as quoting of the contents of the report is prohibited without the prior permission of Clairvoyance Research
Popular Reports
3D Printing in Healthcare Market – Global Outlook & Forecast 2021-2031
3D printing also known as additive manufacturing is a process of making three dimensional solid objects from a CAD model or a digital 3D model. The term "3D printing" can refer to a variety of proc...
Hemophilia Treatment Market – Global Outlook & Forecast 2021-2031
Hemophilia is a rare inherited bleeding disorder in which the blood does not clot properly which leads to spontaneous bleeding as well as bleeding following injuries or surgery. Blood contains prot...
Halal Nutraceuticals and Vaccines – Global Outlook & Forecast 2021-2031
The term halal is particularly associated with Islamic dietary laws and especially meat processed & prepared in accordance with those requirements. Halal is an Arabic word that means permissible. H...
Urinalysis Market – Global Outlook & Forecast 2021-2031
Urinalysis is a test & analysis of urine to detect and manage a wide range of disorders, namely urinary tract infections, kidney disease and diabetes, among others. It includes a group of physical,...
Allergy Diagnostics Market – Global Outlook & Forecast 2021-2031
Allergy is an exaggerated reaction by the immune system in response to exposure to certain foreign substances. These foreign substances are called as allergens and includes pollens, dust mites, mol...
Microcatheters Market – Global Outlook & Forecast 2021-2031
Micro-catheters are a broad term, often used to describe thin wall, small diameter catheters and delivery devices used in minimally invasive applications. Its small build makes it ideal for navigat...
Remote Patient Monitoring Market – Global Outlook & Forecast 2021-2031
Remote patient monitoring (RPM) is a subset of telehealth. It is a technology that enables monitoring of patients outside of conventional clinical settings.
Femtech Market – Global Outlook & Forecast 2021-2031
Femtech is a term applied to a category of software, diagnostics, products and services that focus on women's health.
Telehealth Market – Global Outlook & Forecast 2021-2031
Telehealth is a broader array of digital healthcare activities & services and can be defined as distribution of health-related services & information including medical care, provider & patient educ...
Sleep Apnea Devices Market – Global Outlook & Forecast 2021-2031
Sleep apnea is a condition where breathing is interrupted during sleep. It is considered a serious sleep disorder in which breathing repeatedly stops and starts.
Medtech CDMO Market – Global Outlook & Forecast 2021-2031
A MedTech CDMO is a company that serves other companies in the medical device industry on contract basis and provides comprehensive services ranging from design & development, prototyping, tooling,...
Wearable Medical Devices Market – Global Outlook & Forecast 2021-2031
Wearable medical devices are electronic devices that are designed to collect the data of users' personal health and exercise. It offers a convenient means of monitoring many physiological features,...